This is the 7- year update of the consortium study on 2,142 low and intermediate risk patients treated with SBRT (external beam radiation in 5 treatments). We EXPECT all therapies to work well on low risk patients, but the real benefit is for intermediate risk patients who are not candidates for active surveillance. The side effects are very low too (which I can personally attest to). Unfortunately they didn't have erectile function data from all the consortium sites, but SBRT boasts among the highest rates of potency preservation of any therapy.
SBRT has excellent outcomes for inter... - Prostate Cancer N...
Prostate Cancer Network
1,878 members • 883 posts